Insights from recent episode analysis
Audience Interest
Podcast Focus
Publishing Consistency
Platform Reach
Insights are generated by CastFox AI using publicly available data, episode content, and proprietary models.
Total monthly reach
Estimated from 29 chart positions in 29 markets.
By chart position
- 🇦🇺AU · Medicine#7930K to 100K
- 🇨🇦CA · Medicine#8230K to 100K
- 🇺🇸US · Medicine#1145K to 30K
- 🇯🇵JP · Medicine#11100K to 300K
- 🇲🇽MX · Medicine#2830K to 100K
- Per-Episode Audience
Est. listeners per new episode within ~30 days
125K to 396K🎙 Daily cadence·277 episodes·Last published 6d ago - Monthly Reach
Unique listeners across all episodes (30 days)
415K to 1.3M🇯🇵23%🇻🇳23%🇦🇺8%+26 more - Active Followers
Loyal subscribers who consistently listen
166K to 528K
Market Insights
Platform Distribution
Reach across major podcast platforms, updated hourly
Total Followers
—
Total Plays
—
Total Reviews
—
* Data sourced directly from platform APIs and aggregated hourly across all major podcast directories.
On the show
Recent episodes
New GLP-1 Drug Options and More Highlights From the ADA's 2026 Scientific Sessions
Jun 18, 2026
Unknown duration
Why Exercise Still Matters in the GLP-1 Drug Era
Jun 18, 2026
Unknown duration
The Search for a Fentanyl Vaccine
Jun 12, 2026
Unknown duration
New Insights on HFpEF in Patients With Severe Obesity
Jun 5, 2026
Unknown duration
Ebola Outbreak Update
May 29, 2026
Unknown duration
Social Links & Contact
Official channels & resources
Official Website
Login
RSS Feed
Login
| Date | Episode | Description | Length | ||||||
|---|---|---|---|---|---|---|---|---|---|
| 6/18/26 |  New GLP-1 Drug Options and More Highlights From the ADA's 2026 Scientific Sessions | Rita Kalyani, MD, chief scientific and medical officer at the American Diabetes Association, discusses the latest diabetes and obesity research, including a novel oral GLP-1 drug, a combined semaglutide-amylin analogue injection, data from China on high-dose mazdutide, and more. Related Content: A New GLP-1 Pill for Diabetes, Semaglutide With Amylin, Data From China, and More From ADA 2026 | — | ||||||
| 6/18/26 |  Why Exercise Still Matters in the GLP-1 Drug Era | JAMA Medical News Director Jennifer Abbasi and Staff Writer Samantha Anderer discuss "In Obesity Treatment, Physical Activity's Benefits Go Beyond Weight Loss, Says AHA." Related Content: In Obesity Treatment, Physical Activity's Benefits Go Beyond Weight Loss, Says AHA | — | ||||||
| 6/12/26 |  The Search for a Fentanyl Vaccine | JAMA Medical News Director Jennifer Abbasi and Associate Managing Editor Kate Schweitzer discuss "Inside the Push for a Fentanyl Vaccine." Related Content: Inside the Push for a Fentanyl Vaccine | — | ||||||
| 6/5/26 |  New Insights on HFpEF in Patients With Severe Obesity | JAMA Medical News Director Jennifer Abbasi and Associate Managing Editor Kate Schweitzer discuss "HFpEF May Be a Different Disease in Patients With Severe Obesity." Related Content: HFpEF May Be a Different Disease in Patients With Severe Obesity | — | ||||||
| 5/29/26 |  Ebola Outbreak Update | JAMA Medical News Director Jennifer Abbasi and Associate Managing Editor Kate Schweitzer discuss "A Rare Ebola Virus Is Spreading in the DRC—Here's What to Know." Related Content: A Rare Ebola Virus Is Spreading in the DRC—Here's What to Know | — | ||||||
| 5/29/26 |  Is There a Doctor on the Ship? | Joining from quarantine, Stephen Kornfeld, MD, discusses his experience stepping in as the ship's physician when hantavirus transformed his vacation cruise into a global public health concern. Related Content: Hantavirus Outbreak: First Test of US Public Health Response After WHO Withdrawal When Hantavirus Sickened the Ship's Physician, Stephen Kornfeld, MD, Stepped Up | — | ||||||
| 5/22/26 |  Bangladesh's New Measles Crisis | JAMA Medical News Director Jennifer Abbasi and Staff Writer Samantha Anderer discuss "More Than 19 000 Measles Cases in a Month—What the Current Outbreak in Bangladesh Signals to the World." Related Content: More Than 19 000 Measles Cases in a Month—What the Current Outbreak in Bangladesh Signals to the World | — | ||||||
| 5/15/26 |  New Obesity Definition Stirs Debate | JAMA Medical News Director Jennifer Abbasi and Associate Managing Editor Kate Schweitzer discuss "Experts Debate How Obesity Should Be Defined and Diagnosed." Related Content: Experts Debate How Obesity Should Be Defined and Diagnosed | — | ||||||
| 5/8/26 |  Multi-Cancer Blood Tests Have Arrived | JAMA Medical News Director Jennifer Abbasi and Lead Senior Staff Writer Rita Rubin discuss "These Blood Tests May Detect Dozens of Cancers, but Will They Save Lives?" Related Content: These Blood Tests May Detect Dozens of Cancers, but Will They Save Lives? | — | ||||||
| 5/1/26 |  Why GLP-1 Drugs Affect Patients Differently | JAMA Medical News Associate Managing Editor Kate Schweitzer and Staff Writer Samantha Anderer discuss "Weight Loss, Adverse Effects With GLP-1 Medications May Be Influenced by Genetics." Related Content: Weight Loss, Adverse Effects With GLP-1 Medications May Be Influenced by Genetics | — | ||||||
Want analysis for the episodes below?Free for Pro Submit a request, we'll have your selected episodes analyzed within an hour. Free, at no cost to you, for Pro users. | |||||||||
| 4/24/26 |  Treating Methamphetamine Use Disorder With an Antidepressant | JAMA Medical News Associate Managing Editor Kate Schweitzer and Staff Writer Samantha Anderer discuss "Could a Common Antidepressant Help Treat Methamphetamine Use Disorder?" Related Content: Could a Common Antidepressant Help Treat Methamphetamine Use Disorder? | — | ||||||
| 4/17/26 |  Cicada, the SARS-CoV-2 Variant With a Surprising Trajectory | JAMA Medical News Director Jennifer Abbasi and Lead Senior Staff Writer Rita Rubin discuss "What to Know About Cicada, or BA.3.2, the Latest SARS-CoV-2 Variant Under Monitoring." Related Content: What to Know About Cicada, or BA.3.2, the Latest SARS-CoV-2 Variant Under Monitoring | — | ||||||
| 4/10/26 |  Highlights From the American College of Cardiology's 2026 Scientific Sessions | Hear the latest on PCSK9 inhibitors, cardiorenal benefits of GLP-1 drugs, and other clinical research in this interview with Katie Berlacher, MD, MS, chair of this year's annual ACC meeting. Related Content: PCSK9 Inhibitors in Diabetes, Tirzepatide's Cardiorenal Effects, Shingles Vaccine, and More From ACC | — | ||||||
| 4/10/26 |  Cancer-Treating Vaccines Are on the Horizon | JAMA Medical News Director Jennifer Abbasi and Lead Senior Staff Writer Rita Rubin discuss "How mRNA Vaccines Could Help Treat Cancer." Related Content: How mRNA Vaccines Could Help Treat Cancer | — | ||||||
| 4/3/26 |  What Happens When Patients With Decompensated Cirrhosis Stop Drinking? | JAMA Medical News Director Jennifer Abbasi and Associate Managing Editor Kate Schweitzer discuss "New Hope for Patients With Advanced Alcohol-Related Cirrhosis Who Stop Drinking." Related Content: New Hope for Patients With Advanced Alcohol-Related Cirrhosis Who Stop Drinking | — | ||||||
| 3/27/26 |  What's New in the Updated Lipid Guidelines? | JAMA Medical News Director Jennifer Abbasi and Associate Managing Editor Kate Schweitzer discuss "What to Know About the New Lipid Guidelines." Related Content: What to Know About the New Lipid Guidelines | — | ||||||
| 3/20/26 |  The Health Costs of EPA's Heavy Metal Air Pollution Rollbacks | JAMA Medical News Associate Managing Editor Kate Schweitzer and Staff Writer Samantha Anderer discuss "Why the EPA's Reversal on Heavy Metal Air Pollution Is Cause for Concern." Related Content: Why the EPA's Reversal on Heavy Metal Air Pollution Is Cause for Concern | — | ||||||
| 3/13/26 |  PrEP Prevents HIV—If Patients Can Get It | JAMA Medical News Director Jennifer Abbasi and Associate Managing Editor Kate Schweitzer discuss "After a Decade of Progress Against HIV, PrEP Enters a Precarious Era." Related Content: After a Decade of Progress Against HIV, PrEP Enters a Precarious Era | — | ||||||
| 3/6/26 |  AI Tools for Patients Have Arrived | JAMA Medical News Director Jennifer Abbasi and Lead Senior Staff Writer Rita Rubin discuss "Are AI Tools Ready to Answer Patients' Questions About Their Medical Care?" Related Content: Are AI Tools Ready to Answer Patients' Questions About Their Medical Care? | — | ||||||
| 2/27/26 |  Why the Low Carb vs Low Fat Debate Misses the Point | JAMA Medical News Associate Managing Editor Kate Schweitzer and Staff Writer Samantha Anderer discuss "In the Low-Carb vs Low-Fat Debate, Study Suggests Food Quality Matters More for Heart Health." Related Content: In the Low-Carb vs Low-Fat Debate, Study Suggests Food Quality Matters More for Heart Health | — | ||||||
| 2/20/26 |  What's New in the Dietary Guidelines for Americans? | JAMA Medical News Director Jennifer Abbasi and Associate Managing Editor Kate Schweitzer discuss "What Nutrition Experts Say About the New Dietary Guidelines for Americans." Related Content: What Nutrition Experts Say About the New Dietary Guidelines for Americans | — | ||||||
| 2/13/26 |  ICE Raids Are Jeopardizing Health Care Access | JAMA Medical News Associate Managing Editor Kate Schweitzer and Lead Senior Staff Writer Rita Rubin discuss "US Patients Getting ICE-d-Out of Health Care." Related Content: US Patients Getting ICEd-Out of Health Care | — | ||||||
| 2/6/26 |  Understanding COVID-19 Vaccine–Associated Myocarditis | JAMA Medical News Director Jennifer Abbasi and Associate Managing Editor Kate Schweitzer discuss "Mechanisms Are Emerging for COVID-19 Vaccine−Associated Myocarditis." Related Content: Mechanisms Are Emerging for COVID-19 Vaccine−Associated Myocarditis | — | ||||||
| 1/30/26 |  What's Next in Weight-Loss Drugs? | JAMA Medical News Director Jennifer Abbasi and Lead Senior Staff Writer Rita Rubin discuss "Data on 3 New GLP-1 Drugs for Weight Loss That May Be Approved This Year." Related Content: Data on 3 New GLP-1 Drugs for Weight Loss That May Be Approved This Year | — | ||||||
| 1/23/26 |  How Stress May Connect Mental Health and Cardiovascular Disease | In this week's roundup, Associate Managing Editor Kate Schweitzer and Lead Senior Staff Writer Rita Rubin discuss "Stress May Link Depression and Anxiety to Cardiovascular Disease." Related Content: Stress May Link Depression and Anxiety to Cardiovascular Disease | — | ||||||
Showing 25 of 289
Pitch Fit is a Pro feature
See how bookable this show is for guests, which brands already advertise, the per-episode ad value, and the best-fit guest and sponsor profile. The numbers are blurred on the free plan.
How readily this show books outside guests like you.
How proven this show is for host-read sponsorships.
For Guests
ProFor Advertisers
ProUpgrade to Pro to unlock guest cadence, sponsor categories, fit scores, and per-episode ad value for this show.
Chart Positions
32 placements across 29 markets.
Chart Positions
32 placements across 29 markets.